JPMorgan Chase & Co’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Buy |
13,938
+2,459
| +21% | +$103K | ﹤0.01% | 3990 |
|
|
2025
Q1 | $435K | Buy |
11,479
+1,786
| +18% | +$67.6K | ﹤0.01% | 4101 |
|
|
2024
Q4 | $746K | Buy |
9,693
+1,879
| +24% | +$145K | ﹤0.01% | 3959 |
|
|
2024
Q3 | $450K | Buy |
7,814
+448
| +6% | +$25.8K | ﹤0.01% | 4075 |
|
|
2024
Q2 | $305K | Sell |
7,366
-44,006
| -86% | -$1.82M | ﹤0.01% | 4072 |
|
|
2024
Q1 | $3.13M | Buy |
51,372
+51,355
| +302,088% | +$3.13M | ﹤0.01% | 2857 |
|
|
2023
Q4 | $379 | Sell |
17
-81
| -83% | -$1.81K | ﹤0.01% | 5921 |
|
|
2023
Q3 | $2.51K | Hold |
98
| – | – | ﹤0.01% | 5554 |
|
|
2023
Q2 | $1.69K | Sell |
98
-2,435
| -96% | -$41.9K | ﹤0.01% | 5468 |
|
|
2023
Q1 | $31K | Buy |
2,533
+1,008
| +66% | +$12.3K | ﹤0.01% | 5037 |
|
|
2022
Q4 | $54K | Sell |
1,525
-51
| -3% | -$1.81K | ﹤0.01% | 4715 |
|
|
2022
Q3 | $53K | Buy |
1,576
+77
| +5% | +$2.59K | ﹤0.01% | 4687 |
|
|
2022
Q2 | $55K | Sell |
1,499
-754
| -33% | -$27.7K | ﹤0.01% | 4823 |
|
|
2022
Q1 | $345K | Buy |
2,253
+335
| +17% | +$51.3K | ﹤0.01% | 4186 |
|
|
2021
Q4 | $568K | Buy |
1,918
+383
| +25% | +$113K | ﹤0.01% | 3990 |
|
|
2021
Q3 | $425K | Buy |
1,535
+442
| +40% | +$122K | ﹤0.01% | 4051 |
|
|
2021
Q2 | $300K | Buy |
1,093
+596
| +120% | +$164K | ﹤0.01% | 4283 |
|
|
2021
Q1 | $244K | Buy |
497
+125
| +34% | +$61.4K | ﹤0.01% | 4380 |
|
|
2020
Q4 | $308K | Buy |
+372
| New | +$308K | ﹤0.01% | 4003 |
|